Finding 569140 (2024-001)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2024
Accepted
2025-06-30

AI Summary

  • Issue: Periodic performance reports were not filed on time as required by grant guidelines.
  • Impact: This delay means we did not meet compliance requirements for reporting.
  • Next Steps: Establish controls to ensure timely preparation, review, and filing of these reports.

Finding Text

2024-001 - Filing of Periodic Performance Reports Criteria: Per the grant guidelines in State Award ID Number 724-42639/CFDA 93.959, periodic performance reports are required to be filed on a quarterly basis and are due 30 days after the quarter ends. Condition: The periodic performance reports for the year were not filed on a timely basis. Cause: Turnover in management and the accounting department delayed the filing of these reports timely. Effect: The compliance requirement for reporting was not met. Cause: Turnover in management and the accounting department delayed the filing of these reports timely. Effect: The compliance requirement for reporting was not met. Recommendation: Implement controls to ensure that the quarterly periodic performance reports are prepared, reviewed, and filed on a timely basis. Management's Response: Management agrees with this finding. See Corrective Action Plan.

Corrective Action Plan

FINDINGS: FEDERAL AWARD FINDINGS AND QUESTIONED COSTS MATERIAL WEAKNESS FINDING 2024-001: Compliance with filing requirements of quarterly periodic performance Reports (CDFA 93.959) Condition: The periodic performance reports for the year were not filed on a timely basis. Recommendation: Implement controls to ensure that the quarterly periodic performance reports are prepared, reviewed, and filed on a timely basis. Actions Taken or Planned: Management has hired and trained accounting personnel with the requisite knowledge, skills, and background to effectively and timely prepare the quarterly reports. Management plans to implement controls to ensure that the quarterly periodic performance reports are prepared, reviewed, and filed on a timely basis. Anticipated Date of Completion: June 30, 2025 Name of Contact Person: LaRon Washington, Chief Financial Officer

Categories

Reporting

Other Findings in this Audit

  • 1145582 2024-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $187,119
93.959 Block Grants for Prevention and Treatment of Substance Abuse $3,623